Amenorrhea, TRT, and weight gain: what the evidence says

What's this video probably claiming?

Based on the hashtags and caption framing, this creator is likely sharing a personal update about using testosterone replacement therapy (TRT) while navigating amenorrhea, body image changes, and weight fluctuations. The caption is careful, explicitly framing this as a personal journey update rather than medical advice. That's the right instinct. But the implicit message, that TRT is part of managing or accepting hormonal irregularities including period loss, is one that gets repeated across thousands of similar videos without nearly enough nuance. Creators in this space often position weight gain and amenorrhea as side effects they are "pushing through" on TRT, which can normalize hormonal disruption without discussing when that disruption crosses from expected into clinically significant.

What does the science actually show?

Testosterone therapy in people assigned female at birth reliably suppresses gonadotropin release, which reduces estrogen and progesterone production and, in many cases, stops menstruation. A 2019 study by Unger et al. in Andrology found that roughly 63% of transgender men on testosterone reported amenorrhea within six months of starting therapy at standard doses. Weight changes are also well-documented. A 2021 study by Klaver et al. in The Journal of Clinical Endocrinology and Metabolism tracked body composition changes over 12 months in transgender men on testosterone and found significant increases in lean mass but also variable fat redistribution, which many individuals experience subjectively as weight gain, even when total body fat decreases. Neither amenorrhea nor weight shifts are inherently dangerous in the short term, but long-term estrogen suppression without monitoring carries documented risks to bone mineral density that creators rarely mention.

Where does the social media noise diverge from clinical reality?

The gap is in what gets left out. TikTok content about personal TRT journeys tends to center the empowering or manageable aspects and quietly skip the monitoring requirements. Amenorrhea from testosterone is often framed as a win, but clinicians know it is a signal of significant hormonal change that warrants regular labs, not just personal acceptance. Bone density loss is the underreported story here. A study by van Caenegem et al. (2015, JCEM) found that transgender men on testosterone showed reduced bone mineral density compared to cisgender male controls, particularly when estrogen levels were suppressed without sufficient calcium and Vitamin D intake or weight-bearing activity. The social media version of this experience rarely includes a conversation about DXA scans or why estrogen, even on testosterone, should be periodically assessed rather than ignored.

What should you actually know?

If you are on testosterone therapy and experiencing amenorrhea, that is expected and typically not dangerous in the short term. But it is not a reason to stop monitoring your hormonal health. Estrogen does important things beyond menstruation, including protecting bone density, cardiovascular function, and cognitive health. Period loss does not mean those systems are no longer relevant. Weight changes on TRT are real and complex. Lean mass typically increases, but fat redistribution varies significantly by individual, baseline hormone levels, diet, and activity. Anyone using TRT should be working with a provider who checks labs at regular intervals, not relying on TikTok updates, including this one, to understand what their body is doing. Personal journeys are valid. They are not a substitute for clinical oversight.